Status:
RECRUITING
PET/CT GUIDED BIOPSY VERSUS CT GUIDED BIOPSY IN EVALUATION OF SUSPECTED LUNG NEOPLASMS
Lead Sponsor:
All India Institute of Medical Sciences, Bhubaneswar
Conditions:
Lung Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Percutaneous CT guided biopsy is a well-established, standard sampling technique for suspected neoplastic lesions located in peripheral region in lung parenchyma. Inconclusive results on CT guided bio...
Eligibility Criteria
Inclusion
- Age above 18 years
- INR \< 1.2 and platelet counts \> 80,000/mm3
- CT thorax with lung lesion more than 10 mm.
- Accessible lesions for CT-guided biopsy.
Exclusion
- Participants with pre-existing bleeding diathesis like hemophilia, coagulopathy defined by -INR ≥1.2 and Platelet counts ≤ 80,000/mm3
- Participants who refuse to provide consent
- Signs of hypoperfusion like hypotension, cyanosis etc.
- Presence of hypoxemia with SpO2 \< 94 %- measured in a pulse oximeter)
- Pregnant/Lactating female subjects
- Non-cooperative subjects
- Lesions that are inaccessible (decision made on pre-biopsy planning)
- Serum creatinine level more than 2mg/dl.
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT06923098
Start Date
July 1 2023
End Date
December 1 2025
Last Update
April 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
All India Institute of Medical Sciences, Bhubaneswar
Bhubaneswar, Odisha, India, 751019